BN
BioNxt Solutions Inc.
BNXT.CN · CNQ
$0.33 -2.94% (-$0.01)
1M -5.56%
Market Cap $44.2M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.2
39.4% downside
Current Price
$0.33
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BNXT.CN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 591.08%
Asset turnover 0.00x
ROIC 1,661.22%
Debt
0 /100
High Int. coverage -5.30x
Current ratio 0.19x
Net debt/EBITDA N/A
Stability
24 /100
Unstable Rev. volatility 70.26%
EPS volatility 39.63%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BNXT.CN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hugh A. D. Rogers
Employees
25
Headquarters
Vancouver